Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pengcheng Han

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Cell Discovery|July 12, 2022
Broader-species receptor binding and structural bases of Omicron SARS-CoV-2 to both mouse and palm-civet ACE2sLinjie Li, Pu Han, Baihan Huang, et al.
Cell Discovery|October 6, 2020
Broad host range of SARS-CoV-2 and the molecular basis for SARS-CoV-2 binding to cat ACE2Lili Wu, Qian Chen, Kefang Liu, et al.
Molecular Biomedicine|October 14, 2025
Development of a trispecific fusion protein based on angiotensin-converting enzyme 2, glycoprotein 130, and tumor necrosis factor receptor 2 as a promising therapeutic for COVID-19Yongfeng Qiao, Yanjun Han, Lu Zhao, et al.
Cell|January 30, 2022
Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2Pengcheng Han, Linjie Li, Sheng Liu, et al.
Nature Communications|August 24, 2022
Omicron SARS-CoV-2 mutations stabilize spike up-RBD conformation and lead to a non-RBM-binding monoclonal antibody escapeZhennan Zhao, Jingya Zhou, Mingxiong Tian, et al.
Nature Communications|October 21, 2021
Molecular insights into receptor binding of recent emerging SARS-CoV-2 variantsPengcheng Han, Chao Su, Yanfang Zhang, et al.
Cell|June 17, 2021
Binding and molecular basis of the bat coronavirus RaTG13 virus to ACE2 in humans and other speciesKefang Liu, Xiaoqian Pan, Linjie Li, et al.
Immunity|July 1, 2022
Atlas of currently available human neutralizing antibodies against SARS-CoV-2 and escape by Omicron sub-variants BA.1/BA.1.1/BA.2/BA.3Min Huang, Lili Wu, Anqi Zheng, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Cell Discovery|July 12, 2022
Broader-species receptor binding and structural bases of Omicron SARS-CoV-2 to both mouse and palm-civet ACE2sLinjie Li, Pu Han, Baihan Huang, et al.
Cell Discovery|October 6, 2020
Broad host range of SARS-CoV-2 and the molecular basis for SARS-CoV-2 binding to cat ACE2Lili Wu, Qian Chen, Kefang Liu, et al.
Molecular Biomedicine|October 14, 2025
Development of a trispecific fusion protein based on angiotensin-converting enzyme 2, glycoprotein 130, and tumor necrosis factor receptor 2 as a promising therapeutic for COVID-19Yongfeng Qiao, Yanjun Han, Lu Zhao, et al.
Cell|January 30, 2022
Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2Pengcheng Han, Linjie Li, Sheng Liu, et al.
Nature Communications|August 24, 2022
Omicron SARS-CoV-2 mutations stabilize spike up-RBD conformation and lead to a non-RBM-binding monoclonal antibody escapeZhennan Zhao, Jingya Zhou, Mingxiong Tian, et al.
Nature Communications|October 21, 2021
Molecular insights into receptor binding of recent emerging SARS-CoV-2 variantsPengcheng Han, Chao Su, Yanfang Zhang, et al.
Cell|June 17, 2021
Binding and molecular basis of the bat coronavirus RaTG13 virus to ACE2 in humans and other speciesKefang Liu, Xiaoqian Pan, Linjie Li, et al.
Immunity|July 1, 2022
Atlas of currently available human neutralizing antibodies against SARS-CoV-2 and escape by Omicron sub-variants BA.1/BA.1.1/BA.2/BA.3Min Huang, Lili Wu, Anqi Zheng, et al.
Pageof 7